# OSELTAMIVIR PHOSPHATE — FDA application ANDA209093

Informational only - not investment advice.

Application ANDA209093 · type ANDA · FDA status: approved · original approval 2017-05-17

Listed sponsor: AMNEAL PHARMS · [AMRX company profile](/company/AMRX/) · exact_unique

Sponsor as listed in Drugs@FDA at retrieval (2026-08-07); FDA sponsor listings can lag ownership transfers.

## FDA application facts

| Product | FDA-listed trade name | Active ingredient | Dosage form | Route | Strength | Marketing status | TE code | RLD |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 001 | OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | CAPSULE | ORAL | EQ 30MG BASE | Prescription | AB | No |
| 002 | OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | CAPSULE | ORAL | EQ 45MG BASE | Prescription | AB | No |
| 003 | OSELTAMIVIR PHOSPHATE | OSELTAMIVIR PHOSPHATE | CAPSULE | ORAL | EQ 75MG BASE | Prescription | AB | No |

## Orange Book patent and exclusivity listings

No Orange Book patent or exclusivity listings joined to this application.

Patent and exclusivity dates are regulatory listings from the FDA Orange Book; no relationship to revenue or future sales is stated or implied.

## Compound cross-links

- OSELTAMIVIR PHOSPHATE · UNII 4A3O49NGEZ · [lmmol compound PGZUMBJQJWIWGJ-ONAKXNSWSA-N](https://lmmol.com/compound/PGZUMBJQJWIWGJ-ONAKXNSWSA-N)

Ingredient–compound links use FDA openFDA/GSRS identifiers and an exact lmmol InChIKey join. Ingredient names cannot create a link.

## Related pages

- [Sponsor company](/company/AMRX/)
- [FDA-approved application index](/drug/)

Sources: https://www.fda.gov/drugs/drug-approvals-and-databases/drugsfda-data-files · https://www.fda.gov/drugs/drug-approvals-and-databases/orange-book-data-files · https://api.fda.gov/drug/drugsfda.json?search=application_number:ANDA209093. FDA data retrieved 2026-08-07.

Regulatory listing data as published by FDA; not medical or investment advice.